Maintenance treatment with the immunomodulator MGN1703, a Toll-like receptor 9 (TLR9) agonist, in patients with metastatic colorectal carcinoma and disease control after chemotherapy: a randomised, double-blind, placebo-controlled trial
Crossref DOI link: https://doi.org/10.1007/s00432-014-1682-7
Published Online: 2014-05-10
Published Print: 2014-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schmoll, Hans-Joachim
Wittig, Burghardt
Arnold, Dirk
Riera-Knorrenschild, Jorge
Nitsche, Dieter
Kroening, Hendrik
Mayer, Frank
Andel, Johannes
Ziebermayr, Reinhard
Scheithauer, Werner
License valid from 2014-05-10